Details for New Drug Application (NDA): 211413
✉ Email this page to a colleague
The generic ingredient in CEFAZOLIN SODIUM is cefazolin sodium. There are twenty-seven drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the cefazolin sodium profile page.
Summary for 211413
Tradename: | CEFAZOLIN SODIUM |
Applicant: | Hq Spclt Pharma |
Ingredient: | cefazolin sodium |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 211413
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CEFAZOLIN SODIUM | cefazolin sodium | POWDER;INTRAVENOUS | 211413 | NDA | WG Critical Care, LLC | 44567-840 | 44567-840-25 | 25 VIAL in 1 CARTON (44567-840-25) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (44567-840-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | EQ 2GM BASE/VIAL | ||||
Approval Date: | May 8, 2023 | TE: | RLD: | Yes |
Complete Access Available with Subscription